NEW YORK (GenomeWeb News) – MDS today reported that its fourth-quarter revenues fell 4 percent, as its Analytical Technologies and Pharma Services units both had declines in revenues year over year.
 
The Toronto-based firm brought in revenues of $322 million for the three-month period ended Oct. 31, compared with revenues of $327 million for the fourth quarter of 2007. MDS said that excluding the impact of foreign exchange and acquisitions and divestitures, the firm’s revenues were up 4 percent.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.